Form 483

Apothecon Pharmaceuticals Private Limited Form 483, 2018-08-24

FDA issued a Form 483 to Apothecon Pharmaceuticals Private Limited on 2018-08-24 with 4 public-safe observations.

483· Form 483 issuedHuman Drugs4 observations

Apothecon Pharmaceuticals Private Limited · Taluka Padra, Vadodara, India · Issued August 24, 2018

Overview

  • 4 public-safe observations are available for this inspection.
  • 2 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

24 Aug 2018
21 CFR 211.125(b)

Examination of issued labels

Cited by Roger F Zabinski

24 Aug 2018
21 CFR 211.125(b)

Examination of issued labels

Cited by Roger F Zabinski

24 Aug 2018
21 CFR 211.192

Quality control unit review of records

Cited by Roger F Zabinski

24 Aug 2018
21 CFR 211.192

Quality control unit review of records

Cited by Roger F Zabinski

Inspected site

APApothecon Pharmaceuticals Private LimitedTaluka Padra, Vadodara, India

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.125(b)Cited across public-safe Form 483 observations2x
21 CFR 211.192Cited across public-safe Form 483 observations2x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 4 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere